-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
MAIA Biotechnology, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2021 to Q2 2024.
- MAIA Biotechnology, Inc. Operating Income (Loss) for the quarter ending June 30, 2024 was -$3.82M, a 18.2% increase year-over-year.
- MAIA Biotechnology, Inc. Operating Income (Loss) for the twelve months ending June 30, 2024 was -$19.1M, a 5.28% decline year-over-year.
- MAIA Biotechnology, Inc. annual Operating Income (Loss) for 2023 was -$20.2M, a 24.8% decline from 2022.
- MAIA Biotechnology, Inc. annual Operating Income (Loss) for 2022 was -$16.2M, a 108% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)